** Shares of IDEXX Laboratories fall as much as 6.2% to a 5-month low of $462.00
** Co lowers its 2024 revenue forecast to between $3.9 bln and $3.97 bln from its previous outlook of $3.93 bln to $4.04 bln
** IDXX also cuts its annual EPS forecast to $10.82 to $11.20 from $10.84 to $11.33
** Co's Q1 rev of $964.1 mln misses Wall Street estimates of $966.1 mln - LSEG
** YTD, stock down 13.4%
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments